Barentz, a leading global specialty ingredients solutions provider, has announced the opening of a new office for its Pharmaceuticals division in Chesterbrook, Pennsylvania, marking a significant milestone in the company’s North American growth strategy.

The new facility will serve as the central hub for Barentz’s pharmaceutical operations in North America, reinforcing the company’s commitment to expanding its regional presence, enhancing collaboration, and strengthening relationships with customers and principal partners.

Designed as a commercial office, the Chesterbrook location brings together key teams under one roof to improve coordination, increase responsiveness, and support the continued growth of the pharmaceutical business. 

Strategically located in the Philadelphia metropolitan area, the office offers close proximity to major customers, principals, and industry partners, enabling more effective collaboration and faster market access.

Divya Tewari, President Pharmaceuticals North America, said: “This opening symbolizes the power of partnerships. Our progress in North America has only been possible thanks to the trust of our customers and principal partners, as well as the dedication of our team. This is truly a shared achievement.”

“The new office is expected to play a critical role in supporting Barentz’s expanding pharmaceutical business across the region by facilitating closer engagement with stakeholders and enabling the company to operate more effectively at scale.